Tuesday, November 25, 2025 3:37 PM ET
7 hours ago
Republicans push Obamacare tax credit alternatives as enrollment deadline looms1 day ago
Novo Nordisk shares plunge after Alzheimer's drug trial fails to hit key target1 day ago
Eli Lilly hits $1 trillion market value as Novo Nordisk tumbles1 day ago
Why America's broken health system is an opportunity: Cityblock CEO Toyin Ajayi4 days ago
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform7 days ago
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month8 days ago
Congress hemp ban raises fears of mass layoffs and black market growth8 days ago
U.S. employer health plans tap prescriptions that feds say are illegal12 days ago
Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data12 days ago
Rocket Lab posts record third-quarter revenue, launch backlog14 days ago
Trump tells Republicans to send health insurance money 'directly to the people'14 days ago
Trump's deals with Eli Lilly, Novo Nordisk could broaden obesity drug access17 days ago
Startup Omada Health to start prescribing GLP-1s, other obesity medications18 days ago
Here's how much weight loss drugs could cost under Trump's deals with Lilly, Novo18 days ago
Trump announces deal with Eli Lilly, Novo Nordisk to cut weight loss drug prices19 days ago
Eli Lilly to start late-stage trials on amylin obesity drug after promising data19 days ago
Healthy Returns: Pfizer, Novo Nordisk escalate bidding war over Metsera19 days ago
Metsera says Novo Nordisk's new bid is 'superior' to revised Pfizer offer20 days ago
Pfizer tops estimates, raises profit guidance even as sales fall21 days ago
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war21 days ago
Where the blockbuster weight loss drug market stands today — and what's coming next23 days ago
'Trump effect' raises hopes for cannabis rally as investors bet on change23 days ago
Breast cancer drug stock Olema Pharmaceutical could more than double from here24 days ago
This biotech stock has jumped 50% in 3 months26 days ago
We're raising our Eli Lilly price target — what a difference a quarter makes26 days ago
Midi Health introducing testosterone therapy as demand from women spikes26 days ago
Eli Lilly blows past estimates, hikes guidance on Zepbound and Mounjaro sales26 days ago
Merck tops estimates on Keytruda strength and narrows profit outlook26 days ago
FDA to speed up approvals of biosimilars as Trump targets high drug costs26 days ago
Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound27 days ago
CVS beats estimates, hikes guidance as insurance business improves27 days ago
Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery27 days ago
Healthy Returns: What to expect from Eli Lilly, Merck, AbbVie Q3 earnings28 days ago